Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +734.12%
#3 ADO Protocol ADO Protocol +101.66%
#4 Cortex Cortex +93.48%
#5 Ontology Gas Ontology Gas +74.08%
#6 Kinesis Silver Kinesis Silver +53.91%
#7 Magma Finance Magma Finance +27.64%
#8 OpenEden OpenEden +26.06%
#9 PondCoin PondCoin +25.14%
#10 QuantixAI QuantixAI +23.16%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Circio Holding ASA Circio Holding ASA

Circio Holding ASA

CRNA
Rank in Stocks #18608
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in... Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
Share Price
$0.88044964
Last synced: 2026-07-31
Market Cap
$192.54M
Change (1 day)
-0.71%
Change (1 year)
1,362.12%
Country
NO
Trade Circio Holding ASA (CRNA)

Category

Healthcare
P/E ratio for Circio Holding ASA (CRNA)
P/E ratio as of 2026 TTM: 0
According to Circio Holding ASA latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Circio Holding ASA from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.